Publications by authors named "Frederick Wilson"

Claim this Profile
G
Genetic and oncogenic features of RASGRF fusions.
Sreya Das, Daniel S Lenchner, Ellen Jaeger, Lisa Hunihan, Dana F DeSantis, Frederick H Wilson

NPJ Precis Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial.
Mrinal Gounder, Melissa Johnson, Rebecca S Heist, Geoffrey I Shapiro, Sophie Postel-Vinay, Frederick H Wilson

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity analysis of models of gas exchange for lung hyperpolarised Xe MR.
Yohn Taylor, Frederick J Wilson, Mina Kim, Geoff J M Parker

NMR Biomed· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A destabilizing Y891D mutation in activated EGFR impairs sensitivity to kinase inhibition.
Daniel S Lenchner, Zaritza O Petrova, Lisa Hunihan, Kumar D Ashtekar, Zenta Walther, Frederick H Wilson

NPJ Precis Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Lung Function Assessment of Patients Hospitalized With COVID-19 Using H and Xe Lung MRI.
Laura C Saunders, Guilhem J Collier, Ho-Fung Chan, Paul J C Hughes, Laurie J Smith, Frederick J Wilson

Chest· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition.
Lisa Hunihan, Dejian Zhao, Heather Lazowski, Man Li, Yuping Qian, Frederick H Wilson

Clin Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study.
Maitri Kalra, Elizabeth Henry, Kelly McCann, Meghan S Karuturi, Jean G Bustamante Alvarez, Frederick H Wilson

JMIR Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of the Integrin by PET/CT Imaging in the Lungs of Patients After SARS-CoV2 Infection and Comparison to Fibrotic Lungs.
Pauline T Lukey, Frederick J Wilson

J Nucl Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE study.
Andrew J Swift, Frederick Wilson, Marcella Cogliano, Lindsay Kendall, Faisal Alandejani

Thorax· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thoracic Imaging at Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review.
Bojidar A Rangelov, Alexandra L Young, Joseph Jacob, Anthony P Cahn, Sarah Lee, Frederick J Wilson

Int J Chron Obstruct Pulmon Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus Recommendations on the Use of F-FDG PET/CT in Lung Disease.
Delphine L Chen, Safia Ballout, Laigao Chen, Joseph Cheriyan, Gourab Choudhury, Frederick J Wilson

J Nucl Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in PET to assess pulmonary inflammation: A systematic review.
Laurence Vass, Marie Fisk, Sarah Lee, Frederick J Wilson, Joseph Cheriyan

Eur J Radiol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial.
Sarah B Goldberg, Kurt A Schalper, Scott N Gettinger, Amit Mahajan, Roy S Herbst, Frederick H Wilson

Lancet Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical quantification of the integrin αvβ6 by [F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study).
Pauline T Lukey, Christopher Coello, Roger Gunn, Christine Parker, Frederick J Wilson

Eur J Nucl Med Mol Imaging· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of [F]FB-A20FMDV2 as a selective marker for measuring αβ integrin occupancy using positron emission tomography in rodent lung.
Mayca Onega, Christine A Parker, Christopher Coello, Gaia Rizzo, Nicholas Keat, Frederick J Wilson

Eur J Nucl Med Mol Imaging· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor.
Toby M Maher, Juliet K Simpson, Joanna C Porter, Frederick J Wilson, Robert Chan

Respir Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility of compartmental modelling of F-FDG PET/CT to evaluate lung inflammation.
Laurence D Vass, Sarah Lee, Frederick J Wilson, Marie Fisk, Joseph Cheriyan

EJNMMI Phys· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis.
Pauline T Lukey, Stephen A Harrison, Shuying Yang, Yim Man, Beverley F Holman, Frederick J Wilson

Eur Respir J· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Larotrectinib in NTRK-Rearranged Solid Tumors.
Frederick H Wilson, Roy S Herbst

Biochemistry· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amplification of Wild-type Imparts Resistance to Crizotinib in Exon 14 Mutant Non-Small Cell Lung Cancer.
Magda Bahcall, Mark M Awad, Lynette M Sholl, Frederick H Wilson, Man Xu

Clin Cancer Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yale Cancer Center Precision Medicine Tumor Board: one tumour, multiple targets.
Tyler Stewart, Karin Finberg, Zenta Walther, Jeffrey L Sklar, Navid Hafez, Frederick Wilson

Lancet Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERBB Signaling Interrupted: Targeting Ligand-Induced Pathway Activation.
Frederick H Wilson, Katerina Politi

Cancer Discov· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative analysis of dynamic F-FDG PET/CT for measurement of lung inflammation.
Christopher Coello, Marie Fisk, Divya Mohan, Frederick J Wilson, Andrew P Brown

EJNMMI Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.
Arezou A Ghazani, Nelly M Oliver, Joseph P St Pierre, Andrea Garofalo, Irene R Rainville, Frederick H Wilson

Genet Med· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of Lung PET Images: Challenges and Opportunities.
Delphine L Chen, Joseph Cheriyan, Edwin R Chilvers, Gourab Choudhury, Christopher Coello, Frederick J Wilson

J Nucl Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis